Summary
Intuitive Surgical, Inc. (ISRG) reported its first quarter 2022 financial results, showcasing continued revenue growth driven by increased procedure volumes and system placements. Total revenue for the quarter rose 15% year-over-year to $1.49 billion, with significant contributions from instruments and accessories (+15%) and systems (+16%). The company saw a strong rebound in da Vinci procedures, up 19% year-over-year, indicating a recovery from COVID-19 related disruptions and solidifying the value proposition of minimally invasive care. The installed base of da Vinci systems also grew, reaching approximately 6,920 units, underscoring sustained market adoption. Despite the positive top-line growth, gross profit margin saw a slight decrease to 67.9% from 69.9% in the prior year, attributed to higher freight and material costs, lower system ASPs, and increased fixed costs. Operating income saw a modest decline of 2%, impacted by increased investments in R&D and SG&A expenses, which reflect ongoing strategic investments in innovation and operational capabilities. The company maintained a strong balance sheet with $8.40 billion in cash, cash equivalents, and investments as of March 31, 2022, though this balance decreased slightly from the prior quarter due to share repurchases and capital expenditures.
Financial Highlights
45 data points| Revenue | $1.49B |
| Cost of Revenue | $478.00M |
| Gross Profit | $1.01B |
| R&D Expenses | $210.50M |
| SG&A Expenses | $391.10M |
| Operating Expenses | $601.60M |
| Operating Income | $408.10M |
| Net Income | $365.60M |
| EPS (Basic) | $1.02 |
| EPS (Diluted) | $1.00 |
| Shares Outstanding (Basic) | 358.40M |
| Shares Outstanding (Diluted) | 366.70M |
Key Highlights
- 1Total revenue increased 15% year-over-year to $1.49 billion, driven by 16% growth in systems revenue and 15% growth in instruments & accessories revenue.
- 2Da Vinci procedure volume increased 19% year-over-year to approximately 428,000 procedures, indicating a strong recovery and market adoption.
- 3The installed base of da Vinci Surgical Systems grew 13% to approximately 6,920 units.
- 4Systems revenue saw a 16% increase, supported by a 4% rise in da Vinci system placements (311 units) and higher operating lease revenue.
- 5Gross profit margin decreased to 67.9% from 69.9% year-over-year, primarily due to increased freight, material costs, and lower system ASPs.
- 6Operating income declined slightly by 2% to $408 million, reflecting increased investments in R&D and SG&A expenses.
- 7The company ended the quarter with a robust cash, cash equivalents, and investments balance of $8.40 billion.